Beeline reveals Phase 2 lupus data from old Bristol Myers drug

Beeline Medicines fleshed out an impressive mid-stage win in systemic lupus on Wednesday, setting the stage for Phase 3 trials with a former drug from Bristol Myers Squibb. At each of three doses tested, Beeline’s ...